Intrathecal Dexmedetomidine-Fentanyl Combination Versus Fentanyl Alone as Adjuvant to Bupivacaine in Spinal Anesthesia for Above Knee Amputation in Sarcomas of Lower Extremity

The current work evaluated whether the combination of intrathecal dexmedetomidine and fentanyl provides superior postoperative analgesia to fentanyl alone when administered with hyperbaric bupivacaine.

Trial Details

NCT ID
NCT07276867
Phase
NA
Sponsor
National Cancer Institute, Egypt
Status
RECRUITING
Cancer Type
Sarcoma
Interventions
  • Fentanyl + Dexmedetomidine
  • Fentanyl
Locations (sample)
  • Cairo, Egypt|30.06263,31.24967

Key Eligibility Criteria

  • Age from 18 to 60 years.
  • Both sexes.
  • American Society of Anesthesiologists (ASA) physical status of II-III.
  • Height between 150-185 cm.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Sarcoma Trials on Trialify →